Squarepoint Ops LLC Halozyme Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $3.11 Million - $3.98 Million	102,848 Added 1413.52%	110,124 $3.97 Million
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $5.09 Million - $8.63 Million	-154,978 Reduced 95.52%	7,276 $277,000
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $6.26 Million - $9.28 Million	156,204 Added 2581.88%	162,254 $9.23 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $5 Million - $6.72 Million	-129,703 Reduced 95.54%	6,050 $239,000
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $4.2 Million - $5.43 Million	112,412 Added 481.61%	135,753 $5.97 Million
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $1.96 Million - $2.51 Million	-61,190 Reduced 72.39%	23,341 $931,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $1.23 Million - $1.58 Million	38,789 Added 84.8%	84,531 $3.4 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $1.76 Million - $2.12 Million	45,742 New	45,742 $1.86 Million
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $557,159 - $736,041	-14,345 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $41,327 - $53,816	-1,046 Reduced 6.8%	14,345 $598,000
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $397,241 - $671,355	15,391 New	15,391 $657,000
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $1.77 Million - $2.03 Million	-68,646 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $1.12 Million - $1.84 Million	68,646 New	68,646 $1.84 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $1.29 Million - $2.02 Million	-92,668 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $1.12 Million - $1.46 Million	74,870 Added 420.67%	92,668 $1.64 Million
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $314,868 - $366,448	-20,715 Reduced 53.79%	17,798 $276,000
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $1.97 Million - $2.3 Million	-133,459 Reduced 77.61%	38,513 $662,000
Q1 2019 May 15, 2019	BUY	$13.94 - $17.58 $1.19 Million - $1.51 Million	85,674 Added 99.28%	171,972 $2.77 Million
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $467,803 - $654,854	-35,094 Reduced 28.91%	86,298 $1.26 Million
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $1.07 Million - $1.18 Million	63,892 Added 111.12%	121,392 $2.21 Million
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $584,984 - $703,922	34,676 Added 151.93%	57,500 $970,000
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $747,176 - $928,496	-43,797 Reduced 65.74%	22,824 $447,000
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $1.12 Million - $1.39 Million	66,621	66,621 $1.35 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account